Coexistence of MACC1 and NM23‐H1 dysregulation and tumor budding promise early prognostic evidence for recurrence risk of early‐stage colon cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0463|126|2|99-108

ISSN： 0903-4641

Source： APMIS (ELECTRONIC), Vol.126, Iss.2, 2018-02, pp. : 99-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab

By  

Oncology Research and Treatment, Vol. 36, Iss. 10, 2013-09 ,pp. : 554-558

Karger

Access to resources Recommend Favorite

Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early‐stage prostate cancer

By  

CANCER, Vol. 119, Iss. 19, 2013-10 ,pp. : 3446-3453

John Wiley & Sons Inc

Access to resources Recommend Favorite

Baseline and longitudinal plasma caveolin‐1 level as a biomarker in active surveillance for early‐stage prostate cancer

By  

BJU INTERNATIONAL, Vol. 121, Iss. 1, 2018-01 ,pp. : 69-76

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early‐stage tongue squamous cell carcinoma

By  

JOURNAL OF ORAL PATHOLOGY & MEDICINE, Vol. 44, Iss. 4, 2015-04 ,pp. : 266-272

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outcome Following Local‐Regional Recurrence in Women with Early‐Stage Breast Cancer: Impact of Biologic Subtype

By  

THE BREAST JOURNAL, Vol. 21, Iss. 2, 2015-03 ,pp. : 161-167

John Wiley & Sons Inc

Access to resources Recommend Favorite